经尿道1470 nm激光切除术与TURis治疗非肌层浸润性膀胱癌的疗效比较

Comparison on Efficacy of Transurethral 1470 nm Laser Resection and TURis in the Treatment of Non-Muscle Invasive Bladder Cancer

目的对比经尿道1 470 nm激光切除术与经尿道双极等离子电切术(TURis)治疗非肌层浸润性膀胱癌(NMIBC的应用价值。方法回顾性分析2016年7月至2018年6月我院156例NMIBC患者的临床资料,根据治疗术式分为激光组(n=74,经尿道1 470 nm激光切除术)和TURis组(n=82, TURis)。观察两组的手术情况、并发症情况及复发情况。结果激光组的手术时间、出血量、住院时间及并发症发生率均优于TURis组(P <0.05)。两组的术后复发率比较差异无统计学意义(P>0.05)。结论与TURis相比,经尿道1 470 nm激光切除术治疗NMIBC在改善手术情况、降低并发症发生率等方面更具优势。

Objective To compare the application value of transurethral 1 470 nm laser resection and transurethral resection in saline(TURis) in the treatment of non-muscle invasive bladder cancer(NMIBC). Methods The clinical data of 156 NMIBC patients in our hospital from July 2016 to June 2018 were retrospectively analyzed. They were divided into laser group(n = 74, transurethral 1 470 nm laser resection) and TURis group(n = 82, TURis) according to the treatment methods. The operation conditions, complications and recurrence of the two groups were observed. Results The operation time, blood loss, hospitalization time and incidence of complications of the laser group were better than those of the TURis group(P <0.05). No statistical difference was found in the postoperative recurrence rate between the two groups(P >0.05). Conclusions Compared with TURis, transurethral 1 470 nm laser resection in the treatment of NMIBC is more advantageous in improving the operation conditions and reducing the incidence of complications.